Suppr超能文献

新型抗雄激素药物康士得治疗前列腺癌后的睾丸组织学。初步报告。

Testicular histology after treatment with the new antiandrogen Casodex for carcinoma of the prostate. A preliminary report.

作者信息

Bjerklund Johansen T E, Majak M, Nesland J M

机构信息

Surgical Department, Telemark Central Hospital, Porsgrunn, Norway.

出版信息

Scand J Urol Nephrol. 1994 Mar;28(1):67-70. doi: 10.3109/00365599409180473.

Abstract

Five men aged 55-78 years, had received Casodex 50 mg p.o. daily for seven to 12 months. Because of tumour progression orchiectomy was performed. All testes were examined with light- and electronmicroscopy. Evidence of Leydig cell hyperplasia was present in testes from three patients. However, the ultrastructural appearance of the Leydig cells was normal. The spermatogenesis was reduced in all testes, although not significantly different from controls. We believe the Leydig cell hyperplasia reflects an increased proliferative stimulation by luteinizing hormone or a direct effect of Casodex.

摘要

5名年龄在55至78岁之间的男性,每天口服50毫克康士得,持续7至12个月。由于肿瘤进展,进行了睾丸切除术。所有睾丸均进行了光镜和电镜检查。三名患者的睾丸中存在莱迪希细胞增生的证据。然而,莱迪希细胞的超微结构外观正常。所有睾丸的精子发生均减少,尽管与对照组无显著差异。我们认为莱迪希细胞增生反映了黄体生成素增殖刺激的增加或康士得的直接作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验